In this study, we evaluated cardiac and renal injury markers (serum/urinary NGAL, suPAR, galectin-3, NT-proBNP, troponin) in a population of 76 SSc patients and 50 HC. The gene discussed is LCN2; the disease is systemic sclerosis.